The challenges to demonstrating long-term effects of psychostimulant treatment for attention-deficit/hyperactivity disorder

  title={The challenges to demonstrating long-term effects of psychostimulant treatment for attention-deficit/hyperactivity disorder},
  author={Philip L Hazell},
  journal={Current Opinion in Psychiatry},
  • P. Hazell
  • Published 1 July 2011
  • Psychology, Medicine
  • Current Opinion in Psychiatry
Purpose of review Questions about the long-term effects of psychostimulant medication are frequently raised in the public domain. There is a need to articulate the methodological challenges to addressing this question, both to assist in the interpretation of existing research and to inform future research. Recent findings Two peer-reviewed studies and one published report have attempted to address the issue of long-term effects of psychostimulant medication. One is favourable, one found no… 

Long-Term Pharmacotherapy of Adults With Attention Deficit Hyperactivity Disorder: A Literature Review and Clinical Study.

Treatment with stimulants and atomoxetine of adults with ADHD has long-term beneficial effects and is tolerated but more longitudinal studies should be performed.

Methylphenidate for attention-deficit/hyperactivity disorder: Too much of a good thing?

The review concluded that besides the paucity of data, there was no evidence to suggest that short-term effects of treatment were maintained, and the overall conclusion that ‘methylphenidate may improve ADHD symptomatology’ is measured and cautious.

Effect of Treatment Modality on Long-Term Outcomes in Attention-Deficit/Hyperactivity Disorder: A Systematic Review

The combination of pharmacological and non-pharmacological treatment was most consistently associated with improved long-term outcomes and large effect sizes.

Attention deficit hyperactivity disorder in adults

Examination of available literature regarding attention deficit hyperactivity disorder in adults found psychological therapy may be beneficial in adults who continue to experience clinically significant symptoms while receiving pharmacotherapy, and these therapies are generally well tolerated.

Effects of Methylphenidate on Acute Math Performance in Children with Attention-Deficit Hyperactivity Disorder

The degree of improvement on the RASS and on math performance on MPH was highly correlated and younger children with lower math scores improved most on math scores when given psychostimulants.

Long-Term Treatment Outcome in Adult Male Prisoners With Attention-Deficit/Hyperactivity Disorder: Three-Year Naturalistic Follow-Up of a 52-Week Methylphenidate Trial

It is suggested that motivational support and continued medication are important for improved outcome in adult criminal offenders with ADHD after 4 years of methylphenidate treatment.

Fractionating Executive Functions of Adults With ADHD

Adult ADHD patients who were not under the acute effects of medication reported more symptoms related to ADHD, anxiety and depression symptoms and were impaired in the shifting cost measure and phonemic fluency of access to long-term memory.

Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?

It is hypothesized that a prospective randomized, double-blind, placebo-controlled, multicenter trial in individuals stratified for cardiovascular risk factors would allow for an optimized risk assessment and hypothesize that such a trial might be a dedicated risk mitigation strategy for public health.



Long-Term Stimulant Medication Treatment of Attention-Deficit/Hyperactivity Disorder: Results from a Population-Based Study

It is demonstrated that the effectiveness of stimulant medication treatment of ADHD provided throughout childhood is comparable to the efficacy of Stimulant treatment demonstrated in clinical trials.

Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: a placebo-controlled pilot study.

Risperidone treatment appears to be well tolerated and modestly effective when used in combination with psychostimulants for treatment-resistant aggression in children with ADHD.

3-year follow-up of the NIMH MTA study.

By 36 months, the earlier advantage of having had 14 months of the medication algorithm was no longer apparent, possibly due to age-related decline in ADHD symptoms, changes in medication management intensity, starting or stopping medications altogether, or other factors not yet evaluated.

Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment.

Same-day saliva methylphenidate assays suggest that nearly half of the parents are inaccurate informants of their child's ADHD medication adherence and that parents may overestimate actual (physiological) adherence, suggesting the need for interventions to improve accuracy of parental report.

The Role of Alpha2-Adrenergic Agonists in Attention-Deficit/Hyperactivity Disorder

  • F. Sallee
  • Psychology, Medicine
    Postgraduate medicine
  • 2010
This review will encompass the clinical study database for novel formulations of alpha2-adrenergic agonists, enabling the reader to appreciate their place in ADHD treatment as well as the potential utility of a combination approach with psychostimulants for patients with complex ADHD.

The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies

The results show that estimates of ADHD's persistence rely heavily on how one defines persistence, yet, regardless of definition, the analyses show that evidence for ADHD lessens with age.

The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study.

Type or intensity of 14 months of treatment for ADHD in childhood does not predict functioning 6 to 8 years later, and early ADHD symptom trajectory regardless of treatment type is prognostic, implying that children with behavioral and sociodemographic advantage, with the best response to any treatment, will have the best long-term prognosis.

Modifiers of Long-Term School Outcomes for Children with Attention-Deficit/Hyperactivity Disorder: Does Treatment with Stimulant Medication Make a Difference? Results from a Population-Based Study

St stimulant treatment of children with AD/HD was associated with improved reading achievement, decreased school absenteeism, and decreased grade retention, and this study provides support for efforts to ensure that children withAD/HD receive appropriate long-term medical treatment.

A retrospective claims analysis of combination therapy in the treatment of adult attention-deficit/hyperactivity disorder (ADHD)

ATX and LAS are the most likely drugs to be used as monotherapy in managing adult ADHD, and predictors of combination therapy for LAS and for ATX were modeled for patients covered by commercial plans.

Drug therapy for attention‐deficit/hyperactivity disorder‐like symptoms in autistic disorder

  • P. Hazell
  • Psychology, Medicine
    Journal of paediatrics and child health
  • 2007
Substantial benefit in reducing inattention and hyperactivity is seen with atypical antipsychotics such as risperidone and quetiapine, although weight gain and sedation are common side effects.